DK55888A - Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose - Google Patents

Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose

Info

Publication number
DK55888A
DK55888A DK055888A DK55888A DK55888A DK 55888 A DK55888 A DK 55888A DK 055888 A DK055888 A DK 055888A DK 55888 A DK55888 A DK 55888A DK 55888 A DK55888 A DK 55888A
Authority
DK
Denmark
Prior art keywords
hyperlipidaemia
atherosclerosis
derivatives
prophylaxy
pyridoxin
Prior art date
Application number
DK055888A
Other languages
Danish (da)
English (en)
Other versions
DK55888D0 (da
Inventor
Ulrich Speck
Original Assignee
Ulrich Speck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulrich Speck filed Critical Ulrich Speck
Publication of DK55888D0 publication Critical patent/DK55888D0/da
Publication of DK55888A publication Critical patent/DK55888A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
DK055888A 1987-02-18 1988-02-03 Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose DK55888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873705549 DE3705549A1 (de) 1987-02-18 1987-02-18 Verwendung von pyridoxin-derivaten bei der prophylaxe und therapie von hyperlipidaemien und atherosklerose

Publications (2)

Publication Number Publication Date
DK55888D0 DK55888D0 (da) 1988-02-03
DK55888A true DK55888A (da) 1988-08-19

Family

ID=6321453

Family Applications (1)

Application Number Title Priority Date Filing Date
DK055888A DK55888A (da) 1987-02-18 1988-02-03 Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose

Country Status (12)

Country Link
EP (1) EP0282696B1 (fr)
JP (2) JPH0710777B2 (fr)
KR (1) KR950009094B1 (fr)
AT (1) ATE82125T1 (fr)
CA (1) CA1340246C (fr)
DE (2) DE3705549A1 (fr)
DK (1) DK55888A (fr)
EG (1) EG18335A (fr)
ES (1) ES2052609T3 (fr)
GR (1) GR3006693T3 (fr)
HU (1) HUT47850A (fr)
ZA (1) ZA88577B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
US6228858B1 (en) 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US5744451A (en) 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
WO2000022094A2 (fr) * 1998-10-09 2000-04-20 Kansas University Medical Center Procede permettant d'inhiber la modification oxydative des proteines
ATE306489T1 (de) 1999-03-08 2005-10-15 Medicure Inc Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
CA2383252A1 (fr) 1999-08-24 2001-03-01 Medicure International Inc. Traitement des pathologies cardio-vasculaires et connexes
DE60133323T2 (de) 2000-02-29 2009-03-05 Medicure International Inc. Cardioprotektive Phosphonate
WO2001072309A2 (fr) 2000-03-28 2001-10-04 Medicure International Inc. Traitement d'une maladie vasculaire cerebrale
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
JP2004502757A (ja) 2000-07-07 2004-01-29 メディキュア　インターナショナル　インコーポレイテッド ピリドキシンおよびピリドキサール類縁体：心血管系治療薬
CA2520403A1 (fr) * 2003-03-27 2004-10-07 Medicure Inc. Modulation de mort cellulaire
JP2008517956A (ja) 2004-10-28 2008-05-29 メディキュア・インターナショナル・インコーポレーテッド 二重の抗血小板性／抗凝固性ピリドキシン類似体
CA2593793A1 (fr) * 2005-01-05 2006-07-13 Medicure International Inc. Composes et techniques de regulation des niveaux de triglyceride
FR3038227B1 (fr) * 2015-06-30 2018-08-17 Assistance Publique - Hopitaux De Paris Formulation effervescente a base de pyridoxal-5-phosphate
WO2020003363A1 (fr) * 2018-06-25 2020-01-02 学校法人近畿大学 Supplément nutritionnel ou composition pharmaceutique pour prévenir la détérioration des vaisseaux sanguins due à l'impact de l'ingestion de nicotine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3373E (fr) 1904-02-26 1904-10-27 Joseph Louis Felix Garrigou Procédé de traitement des vidanges et déchets organiques, et appareil d'ensemble permettant sa mise en oeuvre
FR6707M (fr) * 1966-04-29 1969-02-17
GB1070120A (en) * 1966-05-06 1967-05-24 Tanabe Seiyaku Co Pyridoxine derivative and the preparation thereof
FR7238M (fr) * 1968-03-27 1969-09-01
FR2035765A1 (en) 1969-03-06 1970-12-24 Inst Rech Scient Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates
JPS5347110B2 (fr) * 1971-11-02 1978-12-19
FR2176509A2 (en) 1972-03-21 1973-11-02 Inst Rech Scient Pyridoxine p-chlorophenoxyisobutyrate prodn - giving very pure product from corresp acid and pyridoxine
JPS5018470A (fr) * 1973-05-31 1975-02-26
FR2260330A1 (en) 1974-02-07 1975-09-05 Innothera Lab Sa Pyridoxine N-oxy nicotinate - hypolipaemiant and hypocholesterolemiant of good therapeutic index
CH607773A5 (en) 1974-12-24 1978-10-31 Steigerwald Arzneimittelwerk Process for the preparation of novel pyridoxine derivatives
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2349330A1 (fr) * 1976-04-29 1977-11-25 Savini Emile Composition destinee au traitement des hyperlipidemies
JPS5347110A (en) * 1976-10-12 1978-04-27 Osaka Bosui Kensetsusha Kk Impermeable wall forming method

Also Published As

Publication number Publication date
JPS63203621A (ja) 1988-08-23
JPH0710777B2 (ja) 1995-02-08
EP0282696A3 (en) 1989-06-14
DE3875760D1 (de) 1992-12-17
JPH07238020A (ja) 1995-09-12
ZA88577B (en) 1988-07-28
GR3006693T3 (fr) 1993-06-30
EP0282696B1 (fr) 1992-11-11
JP2588686B2 (ja) 1997-03-05
EG18335A (en) 1992-09-30
ES2052609T3 (es) 1994-07-16
HUT47850A (en) 1989-04-28
CA1340246C (fr) 1998-12-15
ATE82125T1 (de) 1992-11-15
DE3705549A1 (de) 1988-09-01
KR880009649A (ko) 1988-10-04
KR950009094B1 (ko) 1995-08-14
DK55888D0 (da) 1988-02-03
EP0282696A2 (fr) 1988-09-21

Similar Documents

Publication Publication Date Title
DK55888A (da) Anvendelse af pyridoxinderivater til profylakse og terapi af hyperlipidaemier og aterosklerose
KR950009098B1 (en) Pharmaceutical composition for use in treating clot formation
UA26890C2 (uk) Піримідиhові похідhі, що мають гербіцидhу активhість, спосіб їх отримаhhя, гербіцидhа композиція і спосіб зhищеhhя бур'яhів
DE69230526D1 (de) Polyaminosäure-dispergiermittel
EP0471756A4 (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
BG49719A3 (en) Method for preparing of variants chirudine and their use
DE3273611D1 (en) Infusion solutions for heart therapy
ATE99118T1 (de) Biozide mittel und behandlungsverfahren.
NO301767B1 (no) Salt av clavulansyre
AU8806798A (en) Diphosphonic acid salts for the treatment of osteoporosis
GR3019866T3 (en) Medicament for treating hyperlipidaemia and/or atherosclerosis
ATE52995T1 (de) Nitrifikationshemmendes mittel.
ZA872128B (en) Chlorpheniramine therapy
NO891423L (no) Ikke-klumpdannende produkter, sammensetninger og behandlinger for salter, enkle og komplekse gjoedningsstoffer.
EP0355612A3 (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0286802A3 (fr) Emploi de l'ofloxacine pour le traitement ou la prophylaxie topique des troubles péridontiques
NO303639B1 (no) Nye 2-sakkarinylmetyl- og 4,5,6,7-tetrahydro-2-sakkarinylmetylfosfater, -fosfonater og -fosfinater som er nyttige som inhibitorer for proteolytiske enzymer samt preparater og anvendelse derav
HU9200025D0 (en) Medical preparations for treating depression
ZA871140B (en) Synergistic chemical compositions for treating salmonellosis
DK0514789T3 (fr)
DK786A (da) 1,3,4-trisubstituerede azacycloalkaner og azacycloalkener og salte deraf samt deres fremstilling og anvendelse
DE3863492D1 (de) Stabile 5-fluorouracil-formulierungen.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment